Perimenopause is not something you have to ride out.

Perimenopause typically begins in the late thirties or forties and can run for eight to ten years. It is not a switch. Progesterone usually falls first and fastest, which is why sleep and anxiety are often the earliest complaints. Estradiol then becomes erratic — spiking and crashing rather than declining smoothly — which drives hot flashes, migraines, and the sense that your emotional baseline moved without your permission. Testosterone, which women produce in meaningful amounts, drifts down across the same window and takes libido, drive and lean mass with it.

None of this is a character flaw, a stress problem, or something to fix with more discipline. It is endocrinology, and it is measurable.

• Waking at 2–4 a.m. and not getting back to sleep — often the first sign, and often blamed on stress.
• New anxiety or irritability with no situational cause.
• Hot flashes and night sweats, from barely noticeable to disabling.
• Brain fog: word-finding trouble, dropped threads, a sense of slower processing.
• Weight redistributing to the midsection despite unchanged diet and training.
• Joint aches, dry skin, thinning hair.
• Libido that quietly disappeared, and discomfort that makes it easier not to think about.

Two reasons. First, most standard panels do not measure what matters — a TSH and a total testosterone will miss almost all of this. Second, reference ranges are built from the general population across all ages. Being within range at 47 tells you that you resemble other 47-year-olds. It does not tell you whether your current levels are compatible with sleeping through the night.

We run a 65-biomarker panel at Quest: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG, LH and FSH, a full thyroid panel, insulin and metabolic markers, inflammatory markers, lipids and micronutrients. Then we read it against your symptoms, not against an average.

There is no single protocol. Depending on where you are in the transition, therapy may involve estradiol, progesterone, low-dose testosterone, thyroid support, or targeted correction of an insulin or nutrient problem that is amplifying everything else. Prescribed therapies are dispensed through FDA-registered compounding pharmacies and licensed pharmacy partners when available.

What is consistent is the method: measure, treat conservatively, retest at six to eight weeks, and titrate. Safety in hormone therapy comes from monitoring, not from avoidance.

Much of the fear around hormone therapy traces back to early interpretations of the Women’s Health Initiative in the early 2000s, which used a specific older formulation in a population with an average age around 63 — many of them more than a decade past menopause. The reporting was blunt, the nuance was lost, and a generation of women stopped being offered treatment.

Clinical understanding has moved considerably since then, particularly around timing, formulation and route of administration. That does not mean hormone therapy is right for everyone. It means the decision belongs to you and a physician looking at your history and your labs — not to a headline. If your history makes you a poor candidate, we will tell you plainly.

If you want to go deeper before booking anything, clinicians like Dr. Mary Claire Haver, Dr. Rachel Rubin and Dr. Kelly Casperson have done more than anyone to make this conversation public. We link several of their talks on the Hormone Optimization program page.

Baseline labs, then thirty minutes with a physician who has read them. Everything is virtual; the draw happens at a Quest location near you. See hormone therapy in Chicago or the FAQ.

This article is educational and is not medical advice. Treatment decisions require an individual evaluation by a licensed clinician.